Use Code ELEVATE10 for 10% off any subscription. View Products

Weekly Elevate Watchlist 9/12/21

Weekly Elevate Watchlist 9/12/21

Welcome to the weekly watchlist. Hope everyone is having a great weekend. Let’s start with what to eye tomorrow.

$HVBT, HIVE Blockchain Orders 2,292 M30S+ MicroBT High Performance Bitcoin Miners. Hourly tells the story here. Here’s the trend to eye tomorrow if we get a run here.

$DSS, saw a ton of insider buyers over the weekend. Nice pop in AH on Friday. Let’s see if this get’s some more love tomorrow.

$CYRN, news was on the 8th. Improving and Cyren Partner to Strengthen Phishing Defense for Microsoft 365.  This is looking like another pump. have an eye on this trend in the am. also $1 will be key.

Let’s talk about stocks with catalyst or news coming the coming week and month 

 
 
 

this week these stocks have have news coming, $CALT on the 15th, $BIIB, $PFE and $BNTC on the 17th.

-Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older.

This will be interesting on Friday for the overall market aspect.

$VRCA Verrica Pharmaceuticals (NASDAQ:VRCA) announces that the U.S. FDA has extended the review period for the New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum ((molluscum)), a highly contagious viral skin disease. goal date has been extended by three months to September 23, 2021.. interesting, like to see if this gets some hype into that date. have a close eye on it.

Another one to have on your radar, $CCXI, remember swinging this earlier this year, this one was a beauty swing, they have a FDA decision date on Oct 7th.

New Drug Application (NDA) for avacopan for the treatment of Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis, addressing points raised during the FDA Advisory Committee meeting on May 6, 2021. The FDA has indicated that the filing constitutes a major amendment to the NDA and will result in the setting of a new PDUFA goal date of October 7, 2021.

On the tech levels to eye, this stock 200 SMA is 37.75. WAY up there. looks like the gap as already filled. but something to have on your radar for the rest of the month into Oct 7th.

Here’s the link to the news coming. 

https://www.globenewswire.com/news-release/2021/07/06/2258260/19219/en/ChemoCentryx-Announces-Filing-of-Amendment-to-NDA-Submission-and-Extension-of-the-PDUFA-Review-Period-for-Avacopan-in-the-Treatment-of-ANCA-Associated-Vasculitis.html

Let’s talk about some oversold and/or highly shorted stocks.

$ALF, this one got a ton of hype of this one after the put screens with ads in UBER-LYFT cars in Miami. Finally came back to the earth. Now shorts aren’t stack, but im really liking this base here. HAS TO HOLD this bottom trend. Hard eye on that triangle. 

$HEXO, one look at this daily and you’ll say damn. this one is in the dirt. I want to have a hard eye on this one as well. needs a rebound for sure. Here’s the some support and resistance area to eye here.

$RGS, another to eye there. very very beat up. RSI and MACD in the dirt. Here’s a few support and resistance area to eye here. this is also over 20% short on its float.

$TBPH, solid gap forming here. formed a double bottom at 8. id like to see this get some consistent volume. but one i want to have my eyes this week as well.

Others to eye that are oversold and/or highly shorted. $FPRX, $NBEV, $LCI, $ARDX, $AWH, $SESN, $EOLS, $VTNR.

Here’s the highest shorted stocks in the markets.

Thanks for reading. Be ready and prepared for the week. Remember the overall markets are on the brink of a correction area. Can’t wait to see what happens with that. 

Amazing profits for the team this week. Adapt to the markets by staying calibrated and consistent. Don’t miss out of the next big play. If it moves we know about it. Learn how to read charts, study habits, live scanners and much more. Join the team by clicking the link below. Elevatetrader.com

Share:

DISCLAIMER

The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Elevate Trader) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Elevate Trader to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Elevate Trader or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates. As such, Elevate Trader is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates.

ELEVATE THE WAY YOU TRADE!

Try a trial – for less than a cup of coffee

See what our members say!

Share: